For the quarter ending 2025-10-31, PATH had $115,043K increase in cash & cash equivalents over the period. $25,107K in free cash flow.
| Cash Flow | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|
| Revenue | - | - | 356,624 | 1,429,664 |
| Adjusted cost of revenue-License | - | - | 1,028 | 5,818 |
| Adjusted cost of revenue-Subscription Services | - | - | 33,385 | 142,654 |
| Adjusted cost of revenue-Professional Services And Other | - | - | 21,366 | 59,068 |
| Adjusted sales and marketing | - | - | 133,191 | 583,898 |
| Adjusted research and development | - | - | 60,185 | 242,679 |
| Adjusted general and administrative | - | - | 37,853 | 154,965 |
| Other segment items | - | - | 100,584 | 361,393 |
| Amortization of acquired intangible assets | - | - | 1,408 | 6,711 |
| Interest income | - | - | 12,648 | 49,422 |
| Provision for income taxes | - | - | 2,827 | -4,406 |
| Net income (loss) | 198,839 | 1,584 | -22,555 | 51,794 |
| Depreciation and amortization | 4,513 | 4,230 | 3,253 | 3,215 |
| Amortization of deferred contract acquisition costs | 26,931 | 22,841 | 21,324 | 29,138 |
| Net accretion on marketable securities | 2,085 | 3,332 | 3,630 | 5,226 |
| Stock-based compensation expense | 71,475 | 78,006 | 76,361 | 87,631 |
| Charitable donation of class a common stock | 0 | 0 | 4,187 | 0 |
| Non-cash operating lease expense | 4,213 | 5,314 | 3,377 | 4,137 |
| Abandonment and impairment charges | - | - | - | 0 |
| Benefit from deferred income taxes | -186,950 | -1,000 | 640 | -19,794 |
| Credit loss expense | 4,785 | - | - | - |
| Other non-cash charges (credits), net | -2,197 | 8,764 | -12,704 | 2,275 |
| Accounts receivable | 98,947 | 5,039 | -197,443 | 120,235 |
| Contract assets | 13,632 | 14,054 | 9,460 | -28,188 |
| Deferred contract acquisition costs | 29,315 | 22,348 | 13,954 | 29,500 |
| Prepaid expenses and other assets | -10,773 | 8,077 | 13,074 | 3,163 |
| Accounts payable | -5,695 | 3,319 | -15,025 | 12,902 |
| Accrued expenses and other liabilities | -1,814 | 25,489 | 12,352 | -1,995 |
| Accrued compensation and employee benefits | 22,508 | 21,180 | -72,534 | 25,159 |
| Operating lease liabilities, net | -1,040 | -4,266 | -2,146 | -4,777 |
| Deferred revenue | 21,709 | -53,496 | -60,261 | 70,110 |
| Net cash provided by operating activities | 28,271 | 41,587 | 119,002 | 146,082 |
| Purchases of marketable securities | 207,180 | 146,706 | 153,353 | 308,112 |
| Maturities of marketable securities | 327,947 | 146,051 | 111,083 | 298,808 |
| Purchases of property and equipment | 3,164 | 0 | 12,832 | 7,392 |
| Payments related to business acquisition, net of cash acquired | 0 | 0 | 24,821 | 0 |
| Purchases of investments | - | 0 | - | 0 |
| Other investing, net | 16,839 | - | - | 0 |
| Net cash provided by (used in) investing activities | 100,764 | -655 | -79,923 | -16,696 |
| Repurchases of class a common stock | 0 | 101,576 | 227,525 | 9,348 |
| Proceeds from exercise of stock options | 444 | 221 | 302 | 7,098 |
| Payments of tax withholdings on settlement of equity awards | 15,425 | 14,083 | 12,195 | 17,447 |
| Net (payments) receipts of tax withholdings on sell-to-cover equity award transactions | - | -19 | - | 0 |
| Proceeds from employee stock purchase plan contributions | 3,795 | 3,855 | 4,214 | 2,712 |
| Payment of deferred consideration related to business acquisition | 0 | 0 | - | 0 |
| Repurchase of unvested early exercised stock options | - | - | - | 0 |
| Net cash used in financing activities | -11,167 | -111,602 | -235,204 | -16,985 |
| Effect of exchange rate changes | -2,825 | -1,354 | 17,570 | -6,835 |
| Net decrease in cash, cash equivalents, and restricted cash | 115,043 | -72,024 | -178,555 | 105,566 |
| Cash and cash equivalents at beginning of period | 629,055 | 701,079 | 879,634 | 774,068 |
| Cash and cash equivalents at end of period | 744,098 | 629,055 | 701,079 | 879,634 |
UiPath, Inc. (PATH)
UiPath, Inc. (PATH)